Novo Nordisk | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
ANI Pharmaceuticals USD 2.33M 2.33M 2024-09
Aurora Cannabis CAD 1.29M 768K 2024-12
Bausch Health Companies USD 346M 4M 2024-09
Bristol-Myers Squibb USD 496M 9M 2024-12
Canopy Growth CAD 16.77M 4.51M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Drreddys Laboratories INR 817M 60M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
GlaxoSmithKline 173M 17M 2024-12
Merck USD 328M 2M 2024-12
Novartis USD 275M 11M 2024-12
Novo Nordisk 562M 40M 2024-09
Pacira USD 4.68M 9K 2024-12
Perrigo 43.1M 200K 2024-12
Prestige Brands USD 11.37M 908K 2024-12
Sanofi 62M 17M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
Zoetis USD 51M 6M 2024-12



Novo Nordisk Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.